Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa, 31982, Saudi Arabia.
Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 600 077, Tamil Nadu, India.
Int J Med Sci. 2024 Apr 29;21(6):1165-1175. doi: 10.7150/ijms.94566. eCollection 2024.
Oral cancer is the most heterogeneous cancer at clinical and histological levels. PI3K/AKT/mTOR pathway was identified as one of the most commonly modulated signals in oral cancer, which regulates major cellular and metabolic activity of the cell. Thus, various proteins of PI3K/AKT/mTOR pathway were used as therapeutic targets for oral cancer, to design more specific drugs with less off-target toxicity. This review sheds light on the regulation of PI3K/AKT/mTOR, and its role in controlling autophagy and associated apoptosis during the progression and metastasis of oral squamous type of malignancy (OSCC). In addition, we reviewed in detail the upstream activators and the downstream effectors of PI3K/AKT/mTOR signaling as potential therapeutic targets for oral cancer treatment.
口腔癌在临床和组织学水平上是最具异质性的癌症。PI3K/AKT/mTOR 通路被确定为口腔癌中最常被调节的信号之一,它调节细胞的主要细胞和代谢活性。因此,PI3K/AKT/mTOR 通路的各种蛋白被用作口腔癌的治疗靶点,以设计更具特异性、更少脱靶毒性的药物。本综述阐明了 PI3K/AKT/mTOR 的调控及其在控制口腔鳞状细胞癌(OSCC)进展和转移过程中的自噬和相关凋亡中的作用。此外,我们详细回顾了 PI3K/AKT/mTOR 信号的上游激活剂和下游效应物,作为口腔癌治疗的潜在治疗靶点。